Comparison of antimicrobial resistance profiles among extended-spectrum-β-lactamase-producing and acquired AmpC β-lactamase-producing Escherichia coli isolates from Canadian intensive care units

被引：25
作者：
Baudry, Patricia J. [1 ,2 ]
Nichol, Kim [1 ]
DeCorby, Melanie [1 ,2 ]
Mataseje, Laura [2 ,3 ]
Mulvey, Michael R. [2 ,3 ]
Hoban, Daryl J. [1 ,2 ]
Zhanel, George G. [1 ,2 ]
机构：
[1] Hlth Sci Ctr, Dept Clin Microbiol, Winnipeg, MB R3A 1R9, Canada
[2] Univ Manitoba, Fac Med, Dept Med Microbiol, Winnipeg, MB R3A 1R9, Canada
[3] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 05期
关键词：
D O I：
10.1128/AAC.01176-07
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Resistance profiles were compared among 18 extended-spectrum-beta-lactamase-producing (ESBL) and 27 acquired AmpC beta-lactamase-producing Escherichia coli isolates collected from Canadian intensive care units from 2005 to 2006. ESBL-producing E. coli isolates were more likely to be gentamicin resistant (P < 0.03), fluoroquinolone resistant (P < 0.0001), and multidrug resistant (P < 0.0001) than AmpC-producing E. coli isolates.
引用
收藏
页码：1846 / 1849
页数：4
相关论文
共 13 条
  • [1] Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada
    Boyd, DA
    Tyler, S
    Christianson, S
    McGeer, A
    Muller, MP
    Willey, BM
    Bryce, E
    Gardam, M
    Nordmann, P
    Mulvey, MR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) : 3758 - 3764
  • [2] *CLIN LAB STAND I, 2006, METH DISK SUSC BACT
  • [3] DECORBY MM, 2006, 46 INT C ANT AG CHEM, pC2
  • [4] Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli:: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004)
    Deshpande, Lalitagauri A.
    Jones, Ronald N.
    Fritsche, Thomas R.
    Sader, Helio S.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (06) : 578 - 581
  • [5] Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales
    Hopkins, K. L.
    Batchelor, M. J.
    Liebana, E.
    Deheer-Graham, A. P.
    Threlfalla, E. J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (03) : 180 - 192
  • [6] Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals
    Mulvey, MR
    Bryce, E
    Boyd, DA
    Ofner-Agostini, M
    Land, AM
    Simor, AE
    Paton, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) : 358 - 365
  • [7] Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals
    Mulvey, MR
    Bryce, E
    Boyd, D
    Ofner-Agostini, M
    Christianson, S
    Simor, AE
    Paton, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1204 - 1214
  • [8] Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR
    Pérez-Pérez, FJ
    Hanson, ND
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) : 2153 - 2162
  • [9] Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary health region:: Emergence of CTX-M-15-producing isolates
    Pitout, Johann D. D.
    Church, Deirdre L.
    Gregson, Daniel B.
    Chow, Barbara L.
    McCracken, Melissa
    Mulvey, Michael R.
    Laupland, Kevin B.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1281 - 1286
  • [10] Population-based laboratory surveillance for AmpC β-lactamase-producing Escherichia coli, Calgary
    Pitout, Johann D. D.
    Gregson, Daniel B.
    Church, Deirdre L.
    Laupland, Kevin B.
    [J]. EMERGING INFECTIOUS DISEASES, 2007, 13 (03) : 443 - 448
12